Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00179608
Status:
COMPLETED
Last Update Posted:
2019-11-08
First Post:
2005-09-13
Brief Title:
Study of the Combination of Lenalidomide and DTIC Dacarbazine in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
Sponsor:
Celgene
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
CC-5013-MEL-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Prologue Research International | INDUSTRY |